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The effect of trauma and PTSD on 
telomere length: An exploratory 
study in people exposed to combat 
trauma
Tae Yong Kim  1, Se Joo Kim2, Jong Rak Choi3, Seung-Tae Lee3, Jieun Kim3, In Sik Hwang3,4, 
Hae Gyung Chung1, Jin Hee Choi1, Hae Won Kim  2, Se Hyun Kim5 & Jee In Kang  2
Telomere length has been suggested to be a cellular marker for age-related diseases as well as 
psychosocial stress. The present study investigated whether telomere length is associated with post-
traumatic stress disorder (PTSD) among veterans exposed to combat trauma in the Vietnam War. 
The potentially associated factors on cellular aging were considered. Korean male veterans with 
(n = 122) and without (n = 120) PTSD were included and leukocyte telomere length was measured 
with a quantitative PCR-based technique. As a whole, no significant difference in telomere length was 
found between PTSD and non-PTSD groups. In linear regression analysis stratified by trauma levels, 
among veterans exposed to severe combat (n = 45), PTSD status (B = −1.176, t = −2.259, p = 0.029), 
antidepressant use (B = 0.168, t = 2.528, p = 0.015), and education level (B = 0.019, t = 2.369, p = 0.023) 
affected telomere length. However, among veterans with light-to-moderate combat exposure 
(n = 197), only age (B = −0.007, t = −2.434, p = 0.016) and education level (B = 0.010, t = 2.295, 
p = 0.023) were associated with telomere length. In the Post-hoc analysis, antidepressant use was 
associated with longer telomere length in subjects exposed to severe combat. Our exploratory results 
suggest that PTSD status in combination with severe trauma may be associated with accelerated 
telomere shortening, and that antidepressant use may have a protective effect on telomere dynamics.
Telomeres refer to protective non-coding segments of tandem TTAGGG repeats at the ends of chromosomes1. 
Telomeres play a crucial role in preventing chromosome fusion and maintaining genomic stability2. They may 
shorten during repeated cell divisions, aging, and in response to cumulative exposure to oxidative stress or other 
genotoxic environments3–5. Telomere shortening is therefore used as a biomarker of cellular aging and medical 
mortality6–8.
Much attention has been paid to the role of stress in aging over the past two decades. Since the first report of 
a relationship between perceived stress and shortened telomere length3, shortening of telomere length has been 
suggested to be a promising cellular marker for psychosocial stress3, 9, 10. Recent studies showed that accelerated 
telomere shortening is associated with poorer mental health including depression and anxiety11, and trauma 
exposure12. The prospective Dunedin Study showed that persistent internalizing psychiatric disorders predicted 
telomere shortening after accounting for multiple potential associated factors including childhood maltreatment, 
smoking, and psychotropic medication use, specifically in males13. A recent meta-analysis (n = 14,827) of adult 
psychiatric disorders and telomere length showed that psychiatric disorders as a whole have a robust effect on 
telomere shortening (Hedge g = −0.50, p < 0.001), compared to healthy controls14. Furthermore, a 6-year lon-
gitudinal study showed that patients with depressive and anxiety disorders (n = 2,292) had significant telomere 
shortening even after controlling for lifestyle and health variables, compared to healthy controls11.
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Psychosocial stress is a well-known risk factor for psychiatric disorders. In particular, post-traumatic stress 
disorder (PTSD) is among only a few psychiatric diagnoses that uniquely depend on a triggering external trau-
matic event or stressor15. PTSD has been reported to be significantly associated with premature development of 
age-related diseases including cardiovascular diseases16, 17 and cognitive decline18. Although the biological mech-
anisms linking PTSD to excess medical morbidity and mortality are unclear, severe psychosocial stress in PTSD 
may lead to stress-related oxidative damage to cells and accelerated telomere shortening19.
The present study examined whether leukocyte telomere length is influenced by PTSD status among indi-
viduals exposed to combat trauma. To better understand the association between PTSD and telomere length, we 
performed analyses stratified by trauma exposure levels, given that higher trauma exposure confers a higher risk 
of PTSD20. In addition, the influence of potentially associated factors on cellular aging, including demographic 
factors (age, education, and economic status), alcohol consumption21, smoking status22, and antidepressant med-
ication9 which have been previously reported to be associated with telomere length, were considered for analyses. 
Our main hypothesis was that PTSD status would be associated with decreased telomere length in individuals 
exposed to severe trauma.
Results
Of the 256 people who participated in the interview, data from 14 veterans were not included in the final analysis: 
four veterans who scored 0 on the self-report CES were excluded, 1 sample was excluded due to insufficient DNA, 
and another 9 participants were excluded because they had telomere length values that were outliers based on 
intra-assay CV. Thus, the final analyses included 122 patients with PTSD and 120 control subjects. The mean age 
of the PTSD group was 62.99 years (standard deviation; SD = 3.40 years), while the mean age of the non-PTSD 
group was 62.94 years (SD = 4.41 years). No significant between-group differences were observed in demographic 
characteristics such as age, education level, marital status, or socioeconomic status.
As a whole, no significant difference in relative telomere length was found between PTSD and non-PTSD 
groups based on Student’s t-test (0.64 ± 0.19 vs. 0.64 ± 0.16, p = 0.75). Subjects with PTSD were more likely to 
engage in harmful alcohol drinking based on AUDIT scores, which were 11.59 ± 10.91 in the PTSD group and 
6.71 ± 7.63 in the non-PTSD group (p < 0.001). In addition, the proportions of non- or light smokers and heavy 
smokers were 50% (n = 61) and 50% (n = 61) in the PTSD group versus 39.2% (n = 47) and 60.8% (n = 73) in the 
non-PTSD group, respectively (X2 = 2.873, p = 0.09). In the present sample, 71.3% and 20.8% of subjects with 
and without PTSD had taken psychoactive medications, and the most common medication used was a selective 
serotonin reuptake inhibitor (SSRI).
Combat exposure was classified as severe (≥25) or light-to-moderate (<25) based on CES score based 
on a previous study which reported that higher combat exposure confers a higher risk of PTSD, compared to 
light-to-moderate combat exposure20. Among all participants, 81.4% (n = 197) reported light-to-moderate com-
bat exposure, and 18.6% (n = 45) reported severe combat exposure. No significant difference in relative telomere 
length was found between subjects exposed to severe trauma and subjects exposed to light-to-moderate trauma 
based on Student’s t-test (0.67 ± 0.20 vs. 0.63 ± 0.17, p = 0.30). Among subjects with PTSD, the corresponding 
proportions of light-to-moderate versus severe levels of combat exposure were 72.1% (n = 88) and 27.9% (n = 34), 
respectively. Among subjects without PTSD, the corresponding proportions of light-to-moderate versus severe 
levels of combat exposure were 90.8% (n = 109) and 9.2% (n = 11), respectively. The distribution of CES catego-
ries between PTSD and non-PTSD groups was significantly different (χ2 = 13.98, df = 1, p < 0.001), with a higher 
proportion of severe combat exposure in subjects in the PTSD group than subjects in the non-PTSD group. 
Socio-demographic and clinical characteristics of PTSD and non-PTSD subjects stratified by trauma exposure 
levels (severe vs. light-to-moderate exposure) are presented in the Table 1, and statistics for comparisons among 
the four subgroups are also shown. No significant difference in relative telomere length was observed among the 
four subgroups based on analysis of variance (ANOVA) or analysis of covariance (ANCOVA) with adjustment for 
socio-demographic variables (p = 0.55, adjusted p = 0.39).
Linear regression models of telomere length were tested separately according to the two levels of trauma expo-
sure severity. Linear regression analysis with backward selection was performed using relative telomere length 
(T/S ratio) as the dependent variable and PTSD status, age, education, socioeconomic status, alcohol use, smok-
ing status, and SSRI use as independent variables, based on a priori assumption. Among veterans exposed to 
Characteristics
Severe combat exposure 








(n = 109) F or χ2 p
Age 63.38 ± 3.13 62.82 ± 5.74 62.84 ± 3.50 62.95 ± 4.23 0.16 0.99
Education (years) 10.35 ± 3.28 9.45 ± 4.28 10.38 ± 2.63 10.56 ± 3.03 0.47 0.70
Socioeconomic status: 
High/Medium/Low, n 7/14/13 2/5/4 18/41/29 18/50/41 1.26 0.98
AUDIT score 13.09 ± 10.77 6.73 ± 7.56 11.01 ± 10.97 6.71 ± 7.67 5.79 0.001
Heavy smoker: Yes/No, n 20/14 8/3 41/47 65/44 4.93 0.17
SSRI use: Yes/No, n 22/12 0/11 53/35 19/90 56.74 <0.001
Relative telomere length 0.66 ± 0.21 0.71 ± 0.16 0.64 ± 0.18 0.63 ± 0.16 0.71 0.55
Table 1. Socio-demographic and clinical characteristics of PTSD and non-PTSD subjects stratified by trauma 
exposure levels. AUDIT, Alcohol Use Disorders Identification Test; SSRI, selective serotonin reuptake inhibitor.
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severe combat (n = 45), PTSD status, SSRI use, and education level affected telomere length (F = 3.681, p = 0.019); 
these variables explained 21.2% of the total variance (Table 2). Among veterans with light-to-moderate levels 
of combat exposure (n = 197), only age and education levels were associated with telomere length (F = 5.101, 
p = 0.007) (Table 2).
In the Post-hoc ANCOVA analysis with adjustment for age and education level (fixed factors: PTSD status and 
SSRI use, a dependent variable: telomere length) stratified by trauma levels, PTSD patients on SSRI (n = 22) had 
significantly higher T/S ratios than patients not on SSRI (n = 12) among individuals exposed to severe trauma 
(p = 0.02), while neither PTSD status nor SSRI use were associated with telomere length among individuals 
exposed to light-to-moderate trauma (Fig. 1).
Furthermore, in partial correlation analysis after adjusting for age and education level, a significant nega-
tive correlation between T/S ratio and total CAPS score was found within SSRI non-users (n = 23, p = 0.026, 
r = −0.484), while no correlation was found within SSRI users (n = 22, p > 0.05) among individuals exposed to 
severe combat (Fig. 2).
Discussion
The present study investigated whether leukocyte telomere length is influenced by trauma and PTSD in a rela-
tively homogenous population of older Korean males exposed to the same traumatic event, namely combat in 
the Vietnam War. We demonstrated that PTSD status and SSRI use affected leukocyte telomere length in people 
exposed to severe combat trauma. Our results suggest that PTSD status in combination with severe trauma expo-
sure may accelerate cellular aging as reflected by decreased telomere length, and that SSRI treatment may protect 
against this decrease in telomere length.
Telomere dynamics in humans are affected by various environmental factors and complex pathways through-
out our lifespans. Among the veterans evaluated in this study, while no significant difference was observed in 
T/S ratios between PTSD and non-PTSD groups, several significant factors, including PTSD status, were found 
after adjusting for other factors according to level of trauma exposure severity. The finding of shorter leukocyte 
telomere length in PTSD patients exposed to severe trauma is consistent with the growing evidence that stress 
affects telomere length19, 23. Chronic stress, such as a high perceived stress level, has been reported to be associated 
Significant associated factors B S.E. t p
Severe combat exposure (n = 45)
Model; F = 3.681 Education level 0.019 0.008 2.369 0.023
            p = 0.019 PTSD status −1.176 0.078 −2.259 0.029
    R2 = 0.212 SSRI use 0.168 0.067 2.528 0.015
Constant 0.526 0.094 5.606 <0.001
Light-to-moderate exposure (n = 197)
Model; F = 5.101 Education level 0.010 0.004 2.295 0.023
      p = 0.007 Age −0.007 0.003 −2.434 0.016
           R2 = 0.050 Constant 0.997 0.192 5.201 <0.001
Table 2. Linear regression analysis to predict relative telomere length among combat veterans according to 
trauma exposure levels.
Figure 1. Comparisons of relative telomere length in PTSD and non-PTSD groups of combat veterans 
according to SSRI use and trauma exposure levels.
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with telomere length and health effects24. A recent comprehensive review of PTSD and senescence reported that 
PTSD was associated with accelerated aging and higher medical morbidity and mortality due to age-related dis-
eases25. These findings suggest that the decrease in telomere length (and the inferred acceleration in cellular 
aging) associated with severe stress may be a promising biomarker of psychosocial stress as well as the progres-
sion of age-related diseases or mortality.
However, it is not clear from our results whether telomere length is a long-lasting molecular signature due to 
severe trauma exposure or a molecular signature resulting from a psychiatric illness, namely PTSD. Furthermore, 
significant debate exists over the impact of PTSD development on cellular aging. Unlike our study in which 
decreased telomere length was associated with PTSD status after severe trauma, a recent longitudinal study of 
Dutch soldiers (n = 96, before and 6 months after deployment in Afghanistan) showed that increased telomere 
length was significantly associated with development of PTSD symptoms26. In our analyses stratified by trauma 
levels, telomere length was not associated with PTSD status in veterans with light-to-moderate levels of combat 
exposure. Although it is difficult to directly compare the changes in young soldiers over a 6 month period with 
our cross-sectional findings in old veterans tested several decades after combat exposure, accelerated cellular 
aging seems to have a complex relationship with PTSD symptom and be differentially influenced by potential fac-
tors including levels of trauma exposure and chronicity/severity of PTSD. Since high stress levels can significantly 
affect the duration and symptom severity of PTSD, PTSD status after severe trauma exposure may exert a greater 
influence on telomere length than after light trauma. It is also possible that the severity of trauma exposure may 
serve as a moderator between PTSD and accelerated cellular aging. To verify the effects of trauma exposure and 
PTSD development on telomere dynamics, further multi-wave longitudinal studies are warranted. In addition, to 
examine the impacts of trauma exposure itself on telomere length, it would be helpful to include as comparison 
groups both trauma-unexposed healthy controls and trauma-exposed non-PTSD subjects.
Importantly, our result demonstrated that SSRI use was significantly associated with telomere length; SSRI 
users had relatively greater telomere length ratios than SSRI non-users among those veterans with severe trauma. 
In addition, non-users of SSRI had a significant negative association between telomere length and PTSD symptom 
severity, while this negative association was not present in SSRI users. Similarly, a previous study of major depres-
sion reported a significant negative association between lifetime exposure to untreated depression and telomere 
length, while this negative association was not present in subjects receiving antidepressants9. These differential 
findings in antidepressant users and non-users suggest that active SSRI treatment for PTSD recovery may mitigate 
the potentially harmful effects of PTSD on telomere length in people exposed to traumatic stress. Although the 
cross-sectional nature of our study precludes determining causal relationships between SSRI use and telomere 
length in subjects with PTSD, SSRI treatment may exert a protective effect on accelerated cellular aging via revers-
ing the effects of chronic PTSD on telomere length. A recent prospective study of 27 depressed patients found 
an association between telomere length and SSRI response, and suggested that reduced pre-treatment telomere 
length may be a predictive biomarker of poor treatment responses to SSRI in major depression27. Further pro-
spective studies with multi-wave longitudinal data examining the effects of SSRI interventions on telomere length 
in people exposed to severe trauma might shed light on the role of SSRIs and their pathophysiological mecha-
nisms in PTSD and telomere dynamics.
The question of how PTSD impacts cellular aging remains unclear. Maladaptive autonomic regulation in 
PTSD may be a key mechanism that accelerates cellular aging and mortality. Patients with PTSD have abnor-
mal autonomic oscillations related to hyperarousal symptoms even in response to ordinary situations, and 
Figure 2. Partial correlation between relative telomere length and PTSD symptom scores within SSRI non-
users (n = 23) or within SSRI users (n = 22) among veterans exposed to a severe level of trauma (n = 45).
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re-experience traumatic events, which may lead to severe psychosocial distress and dysfunctional lifestyles28. In 
addition, as Miller et al. proposed, chronic and repeated HPA-axis activation may result in glucocorticoid-related 
oxidative damage to neurons and, in turn, PTSD-related cellular aging29. Another possible biological mecha-
nism linking PTSD and accelerated cellular aging may be chronic inflammatory processes that promote oxidative 
stress. Altered immune system function, including excess inflammation and high levels of cytokines, has been 
implicated in chronic PTSD among traumatized individuals30–32. Taken together, alterations in the autonomic 
nervous system, the HPA axis, and/or inflammatory responses to severe stress may contribute to oxidative stress 
and accelerated cellular aging19. The underlying pathophysiology of PTSD and the link between this and cellular 
aging require additional research.
We also found that education level was significantly associated with leukocyte telomere length. Findings 
regarding an association between education level and telomere length have been inconsistent across studies. 
While several previous studies reported a significant relationship between shorter telomere length and lower 
educational attainment33–35, similar to our finding, some observed no relationship between telomere length and 
education6, 36. Education level may be a proxy risk factor for other predictors of accelerated cellular aging and 
poor health, because individuals with lower educational attainment may have greater stress exposure, poorer 
coping strategies for stress regulation, and dysfunctional life-styles37, 38.
The present study has several potential limitations. First, the subjects in our study consisted of older male vet-
erans (average age 63.0 years (SD = 3.9 years)) exposed to combat trauma approximately 45 years prior. Although 
the relatively narrow age variation of our subjects may be considered strength, present telomere length is likely to 
have been influenced by lifetime cumulative burden including various environmental factors over long periods 
after combat exposure. Second, we did not consider subject-level risk factors, such as genetic polymorphisms 
and early-life adversity, which can affect adult telomere dynamics. In particular, recent studies have shown that 
exposure to early-life adversity may be associated with shortened telomere length, which may then contribute 
to PTSD development and morbidity in later life39, 40. Furthermore, we did not consider the effects of some pos-
sible confounding factors on telomere length, such as body mass index, amount of physical activity and dietary 
intake of anti-oxidant foods. Third, we used only qPCR among multiple methods for assessing telomere length. 
Combined use of qPCR with other sensitive measurements of telomere length such as flow-FISH may aid in 
detection of subtle differences in telomere length in a clinical setting. Finally, our sample consisted of a relatively 
small number of individuals with a severe level of trauma exposure, which may lead to a risk of overfitting in the 
regression model. In addition, multiple testing in the study may potentially increase Type I errors. Despite these 
limitations, we provided evidence of an association among PTSD, severe trauma, and telomere length, indicating 
that mental health and psychosocial stress can affect telomere length.
In summary, the presence of PTSD and SSRI use affected leukocyte telomere length in combat veterans 
exposed to severe combat trauma. Our results suggest that PTSD status in combination with severe trauma may 
be associated with accelerated telomere shortening, and that SSRI use may have a protective effect on telomere 
dynamics. Further prospective research in independent PTSD samples with consideration of potential confound-
ing variables is required to clarify how PTSD development, trauma level, and interventions such as SSRI use are 
interrelated with telomere length.
Methods
Participants. All subjects gave their written informed consent prior to participation. A total of 256 male 
veterans who were on active duty during the Vietnam War (from 1965 to 1973) were recruited through advertise-
ments at the Veterans Health Service (VHS) Medical Center and interviewed based on DSM-IV-TR15 by a trained 
psychiatrist. Exclusion criteria for the study were a history of head trauma, organic brain syndrome including 
cerebrovascular accidents or dementia, psychosis or bipolar disorder, or dependence on substances other than 
alcohol and nicotine. This study was approved by the institutional review board of the VHS Medical Center, 
Seoul, Korea. The methods were performed in accordance with relevant guidelines and regulations.
Assessment of clinical characteristics. The Clinician-Administered PTSD Scale (CAPS), which is one of 
the most useful measures of PTSD41, 42, was applied to assess the presence of PTSD and the frequency and inten-
sity of each PTSD symptom dimension. PTSD status was determined by weighing both the symptom frequency 
and intensity based on the liberal scoring rule43; frequency ≥1 (occurred at least once during the time frame) and 
intensity ≥2 (at least moderately distressing) for each item.
In addition, the Combat Exposure Scale (CES) was used to assess the level of combat trauma experienced by 
veterans44. The CES, a widely used 7-item, 5-point Likert self-rating scale, has demonstrated good internal con-
sistency and reliability in previous research of combat-related PTSD44. Based on the CES results, subjects were 
classified dichotomously as having been exposed to light-to-moderate levels (<25) versus severe levels of combat 
exposure (≥25)20.
The Alcohol Use Disorders Identification Test (AUDIT) was used to identify participants with problematic 
alcohol use45. In addition, long-term smoking exposure was determined by multiplying the number of years 
smoked by the number of packs smoked per day. Then, using a cutoff of 10 pack-years, subjects were classified 
into two groups: non- or light smokers (<10 pack-years) and heavy smokers (≥10 pack-years).
Telomere length measurement. Genomic DNA was prepared from peripheral blood samples 
using a nucleic acid isolation device, the QuickGene-mini80 (FUJIFILM, Tokyo, Japan). Samples were 
normalized in 96-well microtiter plates to a DNA concentration of 20 ng. A standard sample at 100-ng/
μL was used to create a DNA standard of 80 ng/μL, which was then serially diluted to produce standards of 
40-ng/μL, 20-ng/μL, 10-ng/μL, 5-ng/μL, 2.5-ng/μL, and 1.25-ng/μL. Leukocyte telomere length was meas-
ured using the real-time quantitative polymerase chain reaction (qPCR) assay developed by Cawthon46. The 
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primers (5′ → 3′) used for the telomere and the single copy gene (SCG) amplification were as follows: telg 
(0.9 μL, 10 μM): ACACTAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTAGTGT, telc (0.9 μL, 10 μM): 
TGTTAGGTATCCCTATCCCTATCCCTATCCCTATCCCTAACA, SCG beta-globin primer hbgu (0.5 μL, 
10 μM): CGGCGGCGGGCGGCGCGGGCTGGGCGGcttcatccacgttcaccttg, SCG beta-globin primer hbgd 
(0.5 μL, 10 μM): GCCCGGCCCGCCGCGCCCGTCCCGCCG gaggagaagtctgccgtt. The thermal cycling profile 
for the telomere PCR was as follows: 95 °C for 15 min, followed by 2 cycles of 94 °C for 15 s and 52 °C for 15 s, 
32 cycles of 94 °C for 15 s, 62 °C for 10 s and 74 °C for 15 s with fluorescent signal acquisition, 84 °C for 10 s, and 
finally 88 °C for 15 s with signal acquisition. For both the telomere PCR and the SCG PCR, the final reaction 
volume (10 μl) consisted of 2× SYBR Green PCR Master Mix (Bioline Ltd, UK), 100 ng of template, and the 
respective primers. For internal quality control, DNA samples from all participants were simultaneously tested in 
triplicate in two runs. The intra-assay mean value range of the coefficient of variation (CV) from the results of the 
different DNA sample assays was 0.3–22.3%. The average intra-assay CV for the relative telomere to single copy 
gene (T/S) ratio within triplicates was 4.34% after outlier removal.
Statistical analyses. Socio-demographic and clinical characteristics were compared between groups using 
Student’s t-test, ANOVA, or ANCOVA. For categorical variables, group comparisons were performed using the 
chi-square or Fisher’s exact tests when the expected cell counts are small. Partial correlation analysis was con-
ducted to examine relationships between PTSD symptom scores and relative telomere length to adjust for possible 
confounders. Linear regression analysis was used to identify major determinants that best predicted telomere 
length. In addition to PTSD status and trauma exposure levels, when statistical significance was found in the 
Pearson’s correlation analyses or when a factor was reported to be a predictor of telomere length in previous 
studies, these factors were also considered to be independent variables in the regression models. Thus, the effects 
of PTSD status and clinically important variables including age, education, socioeconomic status, alcohol use 
(AUDIT score), smoking status (heavy smokers vs. non- or light smokers), and SSRI use (user vs. non-user) on 
relative telomere length (T/S ratio) were tested using linear regression analysis with backward selection model. 
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, 
USA) version 23.0. Significance level was accepted at p < 0.05, and all tests were two-tailed.
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